Pure Global AI
NCT06380478Recruiting

Safety and Efficacy of the Bi-Aspheric Monofocal IOL

Safety and Efficacy of the Bi-Aspheric Monofocal Intraocular Lens
ICARES Medicus, Inc.ClinicalTrials.govdeviceDevice trial
Verified
Study focus
Disease/Condition
Cataract
Drug/Device/Intervention
aspicio Monofocal IOL
Study type
Observational
Intervention type
device
Sponsor & location
Primary sponsor
ICARES Medicus, Inc.
Location
Taoyuan, Taiwan
Timeline & enrollment
Phase
N/A
Start date
Mar 05, 2024
End date
Dec 25, 2024
Enrollment
30 participants
Primary outcome

CDVA,Defocus curve

Summary

This is an observational, single-center, non-control, open-label post-marketing study.
 Patients implanted with an aspicio™ Monofocal Intraocular Lens will be scheduled for a
 follow-up visit at least 3 months after the surgery to undergo a routine basic
 ophthalmological examination.

ICD-10 classifications
Other cataractCataract, unspecifiedComplicated cataractOther specified cataractSenile cataract
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06380478
Type
Device Trial
About this record

Access comprehensive clinical trial information for NCT06380478 through Pure Global AI's free database. This phase not specified trial is sponsored by ICARES Medicus, Inc. and is currently Recruiting. The study focuses on Cataract. Target enrollment is 30 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.